The Food and Drug Administration proposes updating of 25-year-old mammography standards to help ensure women get breast density information
) By Laurie McGinley Laurie McGinley Reporter covering health and medicine Email Bio Follow March 27 at 10:09 AM The Food and Drug Administration on Wednesday proposed requiring mammogram providers to notify women with dense breasts about how the condition could affect the accuracy of their mammograms and recommend they talk with their doctors about whether they should have additional tests to check for cancer.
Three dozen states already have laws involving breast-density notifications but the new FDA language would establish a minimum standard that would apply nationwide.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
Weiterlesen »
Axsome Therapeutics shares soar after FDA grants breakthrough designation to depression drugAxsome Therapeutics Inc. shares jumped 7% in premarket trade Wednesday, after the U.S. Food and Drug Administration granted breakthrough therapy designation...
Weiterlesen »
FDA proposes rule to notify women with dense breasts of higher cancer risk and imprecise mammogramsThe Food and Drug Administration is proposing a rule that would require doctors to tell women how dense breasts may influence the accuracy of their breast cancer screenings and encourage women with dense breasts to talk to a doctor.
Weiterlesen »
Women, doctors speak about breast implant illnesses at FDA hearingThe FDA is reviewing the safety of breast implants used by millions of American women at a 2-day hearing about their long-term potential health effects.
Weiterlesen »
‘I was not warned’ - Women who say they were sickened by breast implants demand FDA actionAt a hearing, patients, advocates, say the Food and Drug Administration should take steps to warn patients about risks of implants and take some devices off the market.
Weiterlesen »
Hackers could take over some implanted defibrillators, FDA saysThe world's largest medical device company has acknowledged that many of its implanted cardiac defibrillators use an unencrypted wireless protocol that could allow an attacker to change the settings of the lifesaving devices.
Weiterlesen »
Flood of products containing marijuana extract puts FDA in a bindCBD is blurring the line between a drug and a dietary supplement and testing how much the government can police health claims
Weiterlesen »
Flood of CBD products puts FDA in a bindCBD blurs the regulatory line between drugs and supplements, testing how much the government can police health claims
Weiterlesen »
FDA-approved 'breakthrough' heart failure device improves heart function in patients with late-stage diseaseA new device on the market for patients with heart failure is the first device in cardiology to receive a “breakthrough” designation by the Food and Drug Administration.
Weiterlesen »
FDA takes up decades-long debate over breast implant safety
Weiterlesen »